Ichiro Yokomura
Kyoto Prefectural University of Medicine
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Ichiro Yokomura.
European Journal of Radiology | 2001
Yoshinobu Iwasaki; Kazuhiro Nagata; Masaki Nakanishi; Atushi Natuhara; Hidehiko Harada; Yutaka Kubota; Ichiro Yokomura; Shinichi Hashimoto; Masao Nakagawa
OBJECTIVES The aim of the study was to determine the characteristics of septic pulmonary emboli and their prevalence on spiral computed tomographic (CT) scans. METHODS AND MATERIALS We evaluated 65 lesions on spiral CT scans in ten patients with septic pulmonary emboli. Spiral CT scans (10-mm collimation) were obtained at 10-mm intervals from the lung apex to the diaphragm and were compared with posteroanterior chest radiographs obtained within 24 h after CT scanning. RESULTS Only 21 (32%) of the 65 lesions detected on CT scans were also detected on chest radiographs. Peripheral nodules (39 lesions (60%)) were seen in all ten patients, wedge-shaped peripheral lesions (15 lesions (23%)) in nine patients, and infiltrates (11 lesions (17%)) in four patients. Subpleural lesions (45 lesions (69%)) and feeding vessels (35 (54%)) were found in all patients, and cavitary lesions (seven lesions (11%)) were seen in four patients. Subpleural peripheral nodules and wedge-shaped peripheral lesions were seen in nine patients. Thirty-two lesions (49%) ranged in diameter from 10 to 19 mm, and 59 lesions (91%) were less than 30 mm. CONCLUSIONS Spiral CT is useful in detecting septic pulmonary emboli. On spiral CT subpleural peripheral nodules and wedge-shaped peripheral lesions less than 30 mm in diameter are often found in patients with septic pulmonary emboli.
Experimental Lung Research | 2001
Ichiro Yokomura; Yoshinobu Iwasaki; Kazuhiro Nagata; Masaki Nakanishi; Atsushi Natsuhara; Hidehiko Harada; Yutaka Kubota; Mikio Ueda; Tohru Inaba; Masao Nakagawa
Candidemia, a complication often affecting immunocompromised patients, is a common cause of acute lung injury. Yeast-phase Candida albicans has been shown to express a protein that is antigenically and structurally related to Mac-1. C. albicans is reported to stimulate intercellular adhesion molecule 1 (ICAM-1)expression on endothelial cells. In this study, the authors examined the role of ICAM-1 in acute lung injury induced by candidemia. The authors cultured rat pulmonary artery endothelial cells (RPAEC)and investigated the effect of anti-ICAM-1antibodies on adhesion of C. albicans to RPAEC. In addition, the authors administered anti-ICAM-1 antibodies to rats to examine the effect of the antibodies on experimentally induced candidemia. Survival rates, lung wet-to-dry (W/D) weight ratios, bronchoalveolar lavage (BAL) fluid, histopathological findings, and colony-forming units (CFUs)of lung C. albicans were examined. The adherence of C. albicans to RPAEC was significantly decreased by anti-ICAM-1 antibodies. Anti-ICAM-1 antibodies significantly increased survival, decreased lung W/D weight ratios, decreased neutrophil counts in the BAL fluid, reduced microscopic lung injury, and decreased the quantity of lung C. albicans. These results indicate that ICAM-1plays a role in adherence of C. albicans to pulmonary vascular endothelial cells, which likely leads to invasion of lung tissue by the organism.Candidemia, a complication often affecting immunocompromised patients, is a common cause of acute lung injury. Yeast-phase Candida albicans has been shown to express a protein that is antigenically and structurally related to Mac-1. C. albicans is reported to stimulate intercellular adhesion molecule 1 (ICAM-1) expression on endothelial cells. In this study, the authors examined the role of ICAM-1 in acute lung injury induced by candidemia. The authors cultured rat pulmonary artery endothelial cells (RPAEC) and investigated the effect of anti-ICAM-1 antibodies on adhesion of C. albicans to RPAEC. In addition, the authors administered anti-ICAM-1 antibodies to rats to examine the effect of the antibodies on experimentally induced candidemia. Survival rates, lung wet-to-dry (W/D) weight ratios, bronchoalveolar lavage (BAL) fluid, histopathological findings, and colony-forming units (CFUs) of lung C. albicans were examined. The adherence of C. albicans to RPAEC was significantly decreased by anti-ICAM-1 antibodies. Anti-ICAM-1 antibodies significantly increased survival, decreased lung W/D weight ratios, decreased neutrophil counts in the BAL fluid, reduced microscopic lung injury, and decreased the quantity of lung C. albicans. These results indicate that ICAM-1 plays a role in adherence of C. albicans to pulmonary vascular endothelial cells, which likely leads to invasion of lung tissue by the organism.
Clinical and Vaccine Immunology | 2001
Yutaka Kubota; Yoshinobu Iwasaki; Hidehiko Harada; Ichiro Yokomura; Mikio Ueda; Shinichi Hashimoto; Masao Nakagawa
ABSTRACT Recent studies have shown that alveolar macrophages (AMs) not only act as phagocytes but also play a central role as potent secretory cells in various lung diseases, including pneumonia and acute respiratory distress syndrome. The behavior of AMs during disseminated candidiasis, however, is insufficiently elucidated. This study is the first to report disseminated candidiasis in AM-depleted mice and to analyze the effect of AMs on Candida-induced acute lung injury. While all AM-sufficient mice died by day 2 after infection withCandida albicans, no mortality was observed among AM-depleted mice. Unexpectedly, the CFU numbers of C. albicans isolated from the lungs of AM-depleted mice were significantly higher than those for C. albicans isolated from AM-sufficient mice. The lung wet-to-dry weight ratio was lower for AM-depleted mice than for AM-sufficient mice, although this difference was not significant. We found that bronchoalveolar lavage fluid (BALF) from AM-depleted mice in candidemia contained fewer neutrophils than BALF from AM-sufficient mice. In addition, myeloperoxidase activities in lung homogenates of AM-depleted mice were significantly lower than those in homogenates of AM-sufficient mice. A significant decrease in levels of murine macrophage inflammatory protein 2 (MIP-2), a potent chemoattractant for neutrophils, was noted in lung homogenates from AM-depleted mice compared with levels in homogenates from AM-sufficient mice. Immunohistochemical studies using anti-MIP-2 antibodies revealed that AMs were the cellular source of MIP-2 within the lung during candidemia. We observed that AM depletion decreased levels of AM-derived neutrophil chemoattractant, alleviated acute lung injury during candidemia, and prolonged the survival of mice in candidemia, even though clearance of C. albicans from the lungs was reduced.
Experimental Lung Research | 2005
Yoshizumi Takemura; Yoshinobu Iwasaki; Kazuhiro Nagata; Ichiro Yokomura; Sou Tando; Shinji Fushiki; Hiroaki Matsubara
Apoptosis plays an important role in acute lung injury (ALI), and alveolar macrophages (AMs) are known to secrete proinflammatory cytokines and promote alveolar inflammation. The authors have previously reported that AMs can be depleted by inhalation of 1 mM 2-chloroadenosine (2-CA). In this study, the authors evaluated the effect of AM depletion by 2-CA inhalation on apoptosis in Candida-induced ALI. The results of in situ terminal deoxynucleotidyl transferase–mediated dUTP biotin nick end-labeling (TUNEL) and immunohistochemical studies and measurement of cytokine levels and caspase 3 activities in lung homogenates indicated that the Fas-FasL system and apoptosis of alveolar epithelial cells are suppressed by depletion of AMs by 2-CA inhalation.
Respiratory Medicine | 2005
Yoshinobu Iwasaki; Kazuhiro Nagata; Tatsuya Yuba; Shigekuni Hosogi; Kenji Kohno; Shuji Ohsugi; Hiroomi Kuwahara; Yoshizumi Takemura; Ichiro Yokomura
Chest | 2003
Kazuhiro Nagata; Yoshinobu Iwasaki; Yoshizumi Takemura; Hidehiko Harada; Ichiro Yokomura; Shinji Fushiki; Masao Nakagawa
Clinical and Vaccine Immunology | 1999
Yutaka Kubota; Yoshinobu Iwasaki; Hidehiko Harada; Ichiro Yokomura; Mikio Ueda; Shinichi Hashimoto; Masao Nakagawa
Biomedical Research-tokyo | 2007
Shuji Ohsugi; Yoshinobu Iwasaki; Yoshizumi Takemura; Kazuhiro Nagata; Hidehiko Harada; Ichiro Yokomura; Shigekuni Hosogi; Tatsuya Yuba; Naomi Niisato; Hiroaki Miyazaki; Hiroaki Matsubara; Shinji Fushiki; Yoshinori Marunaka
The journal of the Japanese Respiratory Society | 1998
Yoshinobu Iwasaki; Yutaka Kubota; Ichiro Yokomura; Mikio Ueda; Shinichi Hashimoto; Taichiro Arimoto; Toru Inaba; Chihiro Shimazaki; Masao Nakagawa; Shogo Toda
The journal of the Japanese Respiratory Society | 2005
Kuwahara H; Yamada T; Yuba T; Kono K; Shigekuni Hosogi; Osugi S; Kazuhiro Nagata; Ichiro Yokomura; Yoshinobu Iwasaki